新奇性的价值？ - Suppr

Suppr

超能文献

Value of novelty?

作者信息

Ma Philip, Zemmel Rodney

机构信息

McKinsey & Company, 3075A Hansen Way, Palo Alto, California 94304, USA.

出版信息

Nat Rev Drug Discov. 2002 Aug;1(8):571-2. doi: 10.1038/nrd884.

DOI:10.1038/nrd884

PMID:12402497

Abstract

摘要

相似文献

Value of novelty?

Nat Rev Drug Discov. 2002 Aug;1(8):571-2. doi: 10.1038/nrd884.

G-protein-coupled receptor oligomerization and its potential for drug discovery.

Nat Rev Drug Discov. 2002 Oct;1(10):808-20. doi: 10.1038/nrd913.

The impact of systems approaches on biological problems in drug discovery.

Nat Biotechnol. 2004 Oct;22(10):1215-7. doi: 10.1038/nbt1004-1215.

Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.

Chem Biol Drug Des. 2006 Mar;67(3):196-200. doi: 10.1111/j.1747-0285.2006.00371.x.

Modeling the 3D structure of GPCRs: advances and application to drug discovery.

Curr Opin Drug Discov Devel. 2003 May;6(3):353-61.

Molecular targets and cancer therapeutics.

Drug Discov Today. 2004 Dec 15;9(24):1042-4. doi: 10.1016/S1359-6446(04)03287-8.

The journal of pharmacy and pharmacology 2008.

J Pharm Pharmacol. 2009 Jan;61(1):1-2. doi: 10.1211/jpp/61.01.0001.

Perspective from the founding editors. Preface.

Adv Drug Deliv Rev. 2013 Jan;65(1):3-4. doi: 10.1016/j.addr.2012.07.017. Epub 2012 Aug 17.

Seeing is believing--visualizing drug delivery in vitro and in vivo.

Adv Drug Deliv Rev. 2005 Jun 15;57(8):1085-6. doi: 10.1016/j.addr.2005.01.019.

Can cell systems biology rescue drug discovery?

Nat Rev Drug Discov. 2005 Jun;4(6):461-7. doi: 10.1038/nrd1754.

引用本文的文献

The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets.

Cancer Control. 2024 Jan-Dec;31:10732748241241162. doi: 10.1177/10732748241241162.

V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.

Front Endocrinol (Lausanne). 2023 May 24;14:1173601. doi: 10.3389/fendo.2023.1173601. eCollection 2023.

Bioinformatic Analysis of the Perilymph Proteome to Generate a Human Protein Atlas.

Front Cell Dev Biol. 2022 Apr 28;10:847157. doi: 10.3389/fcell.2022.847157. eCollection 2022.

'Teratoid' Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma.

Children (Basel). 2022 Apr 15;9(4):565. doi: 10.3390/children9040565.

Delineating the activation mechanism and conformational landscape of a class B G protein-coupled receptor glucagon receptor.

Comput Struct Biotechnol J. 2022 Jan 20;20:628-639. doi: 10.1016/j.csbj.2022.01.015. eCollection 2022.

Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomes.

Aging Cell. 2022 Jan;21(1):e13488. doi: 10.1111/acel.13488. Epub 2021 Nov 27.

Chemical Probes for Histamine Receptor Subtypes.

Curr Top Behav Neurosci. 2022;59:29-76. doi: 10.1007/7854_2021_254.

Predicting drug approvals: The Novartis data science and artificial intelligence challenge.

Patterns (N Y). 2021 Jul 21;2(8):100312. doi: 10.1016/j.patter.2021.100312. eCollection 2021 Aug 13.

Biased Opioid Ligands.

Molecules. 2020 Sep 16;25(18):4257. doi: 10.3390/molecules25184257.

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development.

Front Pharmacol. 2019 Aug 23;10:840. doi: 10.3389/fphar.2019.00840. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Value of novelty?

Nat Rev Drug Discov. 2002 Aug;1(8):571-2. doi: 10.1038/nrd884.

G-protein-coupled receptor oligomerization and its potential for drug discovery.

Nat Rev Drug Discov. 2002 Oct;1(10):808-20. doi: 10.1038/nrd913.

The impact of systems approaches on biological problems in drug discovery.

Nat Biotechnol. 2004 Oct;22(10):1215-7. doi: 10.1038/nbt1004-1215.

Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.

Chem Biol Drug Des. 2006 Mar;67(3):196-200. doi: 10.1111/j.1747-0285.2006.00371.x.

Modeling the 3D structure of GPCRs: advances and application to drug discovery.

Curr Opin Drug Discov Devel. 2003 May;6(3):353-61.

Molecular targets and cancer therapeutics.

Drug Discov Today. 2004 Dec 15;9(24):1042-4. doi: 10.1016/S1359-6446(04)03287-8.

The journal of pharmacy and pharmacology 2008.

J Pharm Pharmacol. 2009 Jan;61(1):1-2. doi: 10.1211/jpp/61.01.0001.

Perspective from the founding editors. Preface.

Adv Drug Deliv Rev. 2013 Jan;65(1):3-4. doi: 10.1016/j.addr.2012.07.017. Epub 2012 Aug 17.

Seeing is believing--visualizing drug delivery in vitro and in vivo.

Adv Drug Deliv Rev. 2005 Jun 15;57(8):1085-6. doi: 10.1016/j.addr.2005.01.019.

Can cell systems biology rescue drug discovery?

Nat Rev Drug Discov. 2005 Jun;4(6):461-7. doi: 10.1038/nrd1754.

引用本文的文献

The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets.

Cancer Control. 2024 Jan-Dec;31:10732748241241162. doi: 10.1177/10732748241241162.

V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.

Front Endocrinol (Lausanne). 2023 May 24;14:1173601. doi: 10.3389/fendo.2023.1173601. eCollection 2023.

Bioinformatic Analysis of the Perilymph Proteome to Generate a Human Protein Atlas.

Front Cell Dev Biol. 2022 Apr 28;10:847157. doi: 10.3389/fcell.2022.847157. eCollection 2022.

'Teratoid' Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma.

Children (Basel). 2022 Apr 15;9(4):565. doi: 10.3390/children9040565.

Delineating the activation mechanism and conformational landscape of a class B G protein-coupled receptor glucagon receptor.

Comput Struct Biotechnol J. 2022 Jan 20;20:628-639. doi: 10.1016/j.csbj.2022.01.015. eCollection 2022.

Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomes.

Aging Cell. 2022 Jan;21(1):e13488. doi: 10.1111/acel.13488. Epub 2021 Nov 27.

Chemical Probes for Histamine Receptor Subtypes.

Curr Top Behav Neurosci. 2022;59:29-76. doi: 10.1007/7854_2021_254.

Predicting drug approvals: The Novartis data science and artificial intelligence challenge.

Patterns (N Y). 2021 Jul 21;2(8):100312. doi: 10.1016/j.patter.2021.100312. eCollection 2021 Aug 13.

Biased Opioid Ligands.

Molecules. 2020 Sep 16;25(18):4257. doi: 10.3390/molecules25184257.

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development.

Front Pharmacol. 2019 Aug 23;10:840. doi: 10.3389/fphar.2019.00840. eCollection 2019.